Amicus Therapeutics Announces Regulatory and Clinical Updates for AT-GAA in Pompe Disease 09/15/2018 Medications, CRANBURY, N.J., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a global biotechnology...